業績 2019年


  1. Wakabayashi T, Hibi T, Yoneda G, Iwao Y, Sawada Y, Hoshino H, Uemura S, Ban D, Kudo A, Takemura Y, Mishima K, Shinoda M, Itano O, Otsubo T, Endo I, Kitagawa Y, Tanabe M, Egawa H, Yamamoto M.Predictive model for survival after liver resection for noncolorectal liver metastases in the modern era: a Japanese multicenter analysis. J Hepatobiliary Pancreat Sci. 2019 Oct;26(10):441-448. doi: 10.1002/jhbp.654. Epub 2019 Jul 28.
  2. Endo Y, Kitago M, Aiura K, Shinoda M, Yagi H, Abe Y, Oshima G, Hori S, Nakano Y, Itano O, Fukada J, Masugi Y, Kitagawa Y. Efficacy and safety of preoperative 5-fluorouracil, cisplatin, and mitomycin C in combination with radiotherapy in patients with resectable and borderline resectable pancreatic cancer: a long-term follow-up study. World J Surg Oncol. 2019 Aug 16;17(1):145. doi: 10.1186/s12957-019-1687-4.
  3. Nakano Y, Itano O, Shinoda M, Kitago M, Yagi H, Abe Y, Takeuchi A, Takemura Y, Kitagawa Y. Predictive factors for liver volume and function recovery after resection using three-dimensional analysis. HPB (Oxford). 2019 Oct 31:S1365-182X(19)30733-6. doi: 10.1016/j.hpb.2019.10.002. Online ahead of print.
  4. Wakabayashi T, Obara H, Seki M, Shinoda M, Kitago M, Yagi H, Abe Y, Matsubara K, Yamada Y, Oshima G, Oki K, Nagoshi N, Watanabe K, Hibi T, Itano O, Hoshino K, Suzuki N, Kuroda T, Kitagawa Y. Myelopathy due to human T-cell leukemia virus type-1 from the donor after ABO-incompatible liver transplantation. Ann Hepatol. 2019 Mar-Apr;18(2):397-401. doi: 10.1016/j.aohep.2018.06.002. Epub 2019 Apr 17.
  5. Takemura Y, Hibi T, Shinoda M, Obara H, Minagawa T, Kitago M, Yagi H, Abe Y, Matsubara K, Oshima G, Hori S, Hoshino K, Yamada Y, Itano O, Takano Y, Kuroda T, Hasegawa N, Kitagawa Y. Methicillin-resistant Staphylococcus aureus carriers are vulnerable to bloodstream infection after living donor liver transplantation. Clin Transplant. 2019 Dec;33(12):e13753. doi: 10.1111/ctr.13753. Epub 2019 Nov 26.
  6. Wakabayashi T, Yagi H, Tajima K, Kuroda K, Shinoda M, Kitago M, Abe Y, Oshima G, Hirukawa K, Itano O, Kitagawa Y. Efficacy of New Polylactic Acid Nonwoven Fabric as a Hemostatic Agent in a Rat Liver Resection Model. Surg Innov. 2019 Jun;26(3):312-320. doi: 10.1177/1553350619833582. Epub 2019 Mar 21.
  7. Hoshimoto S, Hishinuma S, Shirakawa H, Tomikawa M, Ozawa I, Ogata Y. Outcomes in patients with pancreatic cancer as a secondary malignancy: a retrospective single-institution study. Langenbecks Arch Surg. 2019 Dec;404(8):975-983. doi: 10.1007/s00423-019-01841-7.
  8. Narihiro S, Yoshida M, Ohdaira H, Sato T, Suto D, Hoshimoto S, Suzuki N, Marukuchi R, Kamada T, Takeuchi H, Suzuki Y.A novel fluorescent marking clip for laparoscopic surgery of colorectal cancer: A case report. Int J Surg Case Rep. Int J Surg Case Rep. 2019;64:170-173. doi: 10.1016/j.ijscr.2019.10.024.
  9. Takagi C, Kikuchi Y, Shirakawa H, Hoshimoto S, Tomikawa M, Ozawa I, Hishinuma S, Ogata Y. Predictive Factors for Elevated Postoperative Carbohydrate Antigen 19-9 Levels in Patients With Resected Pancreatic Cancer. Anticancer Res. 2019 Jun;39(6):3177-3183. doi: 10.21873/anticanres.13455.
  10. Hoshimoto S, Hishinuma S, Shirakawa H, Tomikawa M, Ozawa I, Ogata Y. Association of Preoperative Platelet-to-Lymphocyte Ratio with Poor Outcome in Patients with Distal Cholangiocarcinoma. Oncology. 2019;96(6):290-298. doi: 10.1159/000499050.
  11. Takeuchi M, Obara H, Kawakubo H, Shinoda M, Okabayashi K, Mayanagi S, Irino T, Fukuda K, Nakamura R, Wada N, Kitago M, Yagi H, Abe Y, Oshima G, Hori S, Tsuruta M, Ishida T, Yokose T, Hirukawa K, Isobe Y, Sekimoto Y, Harada H, Maeda Y, Shito M, Kondo T, Sato Y, Kitagawa Y. Comparison of olanexidine versus povidone-iodine for preventing surgical site infection in gastrointestinal surgery: study protocol for a multicentre, single-blind, randomised controlled clinical trial.
  12. Matsui S, Okabayashi K, Tsuruta M, Shigeta K, Seishima R, Ishida T, Kondo T, Suzuki Y, Hasegawa H, Shimoda M, Sugimoto S, Sato T, Kitagawa Y. 3. Interleukin-13 and its signaling pathway is associated with obesity-related colorectal tumorigenesis. Cancer Sci. 2019 Jul;110(7):2156-2165.
  13. Suzumura H, Tsuruta M, Hasegawa H, Okabayashi K, Ishida T, Asada Y, Makino A, Okuda S, Kitagawa Y. The impact of the mesorectal apparent diffusion coefficient value on surgical difficulty in laparoscopic anterior resection for rectal cancer. Surg Today. 2019 Mar;49(3):239-244.
  14. Takeuchi M, Takeuchi H, Kawakubo H, Shimada A, Nakahara T, Mayanagi S, Niihara M, Fukuda K, Nakamura R, Suda K, Wada N, Kitagawa Y. Risk factors for lymph node metastasis in non-sentinel node basins in early gastric cancer: sentinel node concept. Gastric Cancer. 2019 Jan;22(1):223-230.
  15. Shimada A, Tsushima T, Tsubosa Y, Booka E, Takebayashi K, Niihara M, Isaka M, Ohde Y, Machida N, Onozawa Y, Yasui H, Takeuchi H, Kitagawa Y. Validity of Surgical Resection for Lymph Node or Pulmonary Recurrence of Esophageal Cancer After Definitive Treatment. World J Surg. 2019 May;43(5):1286-1293.
  16. Shimada A, Takeuchi H, Nishi T, Mayanagi S, Fukuda K, Suda K, Nakamura R, Wada N, Kawakubo H, Nakahara T, Kameyama K, Kitagawa Y. Utility of the one-step nucleic acid amplification assay in sentinel node mapping for early gastric cancer patients. Gastric Cancer. 2019 Oct 30. doi: 10.1007/s10120-019-01016-9. [Epub ahead of print]
  17. Takeuchi M, Kawakubo H, Shimada A, Matsuda S, Nakahara T, Mayanagi S, Irino T,Fukuda K, Nakamura R, Wada N, Takeuchi H, Kitagawa Y. Assessment of lymphatic flow based on the sentinel node concept in early gastric adenocarcinoma that satisfies expanded endoscopic resection criteria. Gastric Cancer. 2019 Nov 14.doi: 10.1007/s10120-019-01026-7. [Epub ahead of print]
  18. Fujita T, Sato T, Sato K, Hirano Y, Fujiwara H, Daiko H. Clinical manifestation, risk factors and managements for postoperative chylothorax after thoracic esophagectomy. J Thorac Dis. 2019 Mar; 11(Suppl 3): S198-S201. doi: 10.21037/jtd.2019.02.31
  19. Uchino M, Ikeuchi H, Hata K, Okada S, Ishihara S, Morimoto K, Sahara R, Watanabe K, Fukushima K, Takahashi K, Kimura H, Hirata K, Mizushima T, Araki T, Kusunoki M, Nezu R, Nakao S, Itabashi M, Hirata A, Ozawa H, Ishida T, Okabayashi K, Yamamoto T, Noake T, Arakaki J, Watadani Y, Ohge H, Futatsuki R, Koganei K, Sugita A, Higashi D, Futami K. Changes in the rate of and trends in colectomy for ulcerative colitis during the era of biologics and calcineurin inhibitors based on a Japanese nationwide cohort study. Surg Today. 2019 Dec;49(12):1066-1073. doi: 10.1007/s00595-019-01845-2. Epub 2019 Jul 15.
  20. Takahashi R, Shinoda K, Ishida T, Hamamoto Y, Morita S, Akita H, Kitaoka S, Tamaki S, Asanuma H, Yoshida T, Jinzaki M, Kameyama K, Oya M. Small Intestinal Perforation Due to a Huge Gastrointestinal Stromal Tumor in a Kidney Transplant Recipient: A Case Report and Literature Review. BMC Nephrol. 2019 Apr 3;20(1):120. doi: 10.1186/s12882-019-1310-5.


  1. 板野 理, 今井 俊一. 【見せます!できる外科医のオペ記事-肝胆膵高度技能医は手術をこう描く】高度技能専門医・指導医の書いたオペ記事 腹腔鏡下胆嚢床切除,リンパ節郭清. 臨床外科 (0386-9857)74巻13号 Page1453-1459(2019.12)
  2. 板野 理, 阿部 雄太, 北川 雄光. 【消化器疾患に対する機能温存・再建手術】肝胆膵領域 可及的実質温存をめざした腹腔鏡下Parenchymal-Sparing Anatomical Liver Resection. 外科 (0016-593X)81巻5号 Page522-526(2019.04).
  3. 藤井 正一(国際医療福祉大学市川病院 消化器外科), 前橋 学, 今井 俊一, 大山 隆史, 板野 理, 吉田 雅博. 【消化器疾患に対する機能温存・再建手術】下部消化管領域 結腸におけるreduced port surgery, needle scopic surgeryの役割. 外科 (0016-593X)81巻5号 Page451-457(2019.04).
  4. 本田 五郎, 板野 理. 【JSES技術認定取得をめざせ!】臓器別:肝臓 技術審査委員からのアドバイス. 臨床外科 (0386-9857)74巻5号 Page608-612(2019.05).
  5. 今井 俊一, 吉田 雅博, 板野 理, 冨田 裕彦. 胆嚢神経内分泌癌(NEC)(図説). 胆道 (0914-0077)33巻5号 Page911-915(2019.12)
  6. 竹村 裕介, 北郷 実, 板野 理, 篠田 昌宏, 八木 洋, 阿部 雄太, 大島 剛, 堀 周太郎, 藤田 優裕, 益田 悠貴, 久保田 直人, 辻川 華子, 川井田 みほ, 北川 雄光. FDG-PET/CTの集積で診断され術中の局所診断に苦慮した非機能性膵神経内分泌腫瘍(PNET)の1切除例 病変の術中検出限界、ピットフォールについて. 膵臓 (0913-0071)34巻1号 Page22-29(2019.02)
  7. 八木 洋, 板野 理, 皆川 卓也, 竹村 裕介, 堀 周太郎, 大島 剛, 阿部 雄太, 北郷 実, 篠田 昌宏, 北川 雄光. 誌上ディベート(第12回) 早期胆嚢癌疑診例のラパコレ Yes vs. No Yesの立場から. 消化器外科 (0387-2645)42巻3号 Page346-352(2019.03).
  8. 松岡信成, 石田隆, 岡林剛史, 鶴田雅士, 横江隆道, 前田祐助, 蛭川和也, 長谷川博俊, 北川雄光. 尿路変向を伴う泌尿器科術後に尿管が原因となって内ヘルニアを来した1例. 日本消化器外科学会雑誌 (0386-9768)52巻10号 Page605-610, 2019